The Iodine Deficiency Drug market size is expected to reach $314.08 billion by 2030 at a CAGR of 10.1%, driven by increasing insufficient iodine intake.
The Intravascular Microaxial LVAD Devices market size is expected to reach $1.02 billion by 2030 at a CAGR of 17.7%, driven by increasing prevalence of cardiovascular diseases.
The Intra-Uterine Contraceptive Devices market size is expected to reach $4.78 billion by 2030 at a CAGR of 6.8%, driven by rising awareness about family planning.
The Intracranial Hematoma Drug market size is expected to reach $2.79 billion by 2030 at a CAGR of 9.7%, driven by rising incidence of traumatic brain injuries.